# Use of Hydrogen Sulphide Donor (N-acetyl Cysteine) in Cases With Acute Ischemic Stroke

> **NCT07749287** · PHASE3 · COMPLETED · sponsor: **Helwan University** · enrollment: 121 (actual)

## Conditions studied

- Ischemic Cerebral Infarction

## Interventions

- **DRUG:** N Acetyl cysteine 600mg
- **DRUG:** Normal (0.9%) saline

## Key facts

- **NCT ID:** NCT07749287
- **Lead sponsor:** Helwan University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2023-01-01
- **Final completion:** 2024-03-01
- **Target enrollment:** 121 (ACTUAL)
- **Last updated:** 2026-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07749287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07749287, "Use of Hydrogen Sulphide Donor (N-acetyl Cysteine) in Cases With Acute Ischemic Stroke". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07749287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*